IDEAYA Biosciences Statistics
Total Valuation
IDYA has a market cap or net worth of $3.04 billion. The enterprise value is $1.92 billion.
| Market Cap | 3.04B |
| Enterprise Value | 1.92B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDYA has 96.69 million shares outstanding. The number of shares has increased by 5.59% in one year.
| Current Share Class | 96.69M |
| Shares Outstanding | 96.69M |
| Shares Change (YoY) | +5.59% |
| Shares Change (QoQ) | +11.82% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 101.77% |
| Float | 90.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 83.34 |
| Forward PS | 36.92 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 52.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.04 |
| Quick Ratio | 8.80 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.46% and return on invested capital (ROIC) is -25.83%.
| Return on Equity (ROE) | -38.46% |
| Return on Assets (ROA) | -24.10% |
| Return on Invested Capital (ROIC) | -25.83% |
| Return on Capital Employed (ROCE) | -41.36% |
| Weighted Average Cost of Capital (WACC) | 4.66% |
| Revenue Per Employee | $251,972 |
| Profits Per Employee | -$2.90M |
| Employee Count | 145 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.62% in the last 52 weeks. The beta is 0.08, so IDYA's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -1.62% |
| 50-Day Moving Average | 35.63 |
| 200-Day Moving Average | 33.86 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (20 Days) | 1,062,997 |
Short Selling Information
The latest short interest is 9.08 million, so 9.39% of the outstanding shares have been sold short.
| Short Interest | 9.08M |
| Short Previous Month | 9.18M |
| Short % of Shares Out | 9.39% |
| Short % of Float | 10.00% |
| Short Ratio (days to cover) | 9.87 |
Income Statement
In the last 12 months, IDYA had revenue of $36.54 million and -$420.01 million in losses. Loss per share was -$4.52.
| Revenue | 36.54M |
| Gross Profit | -376.05M |
| Operating Income | -463.04M |
| Pretax Income | -420.01M |
| Net Income | -420.01M |
| EBITDA | -460.33M |
| EBIT | -463.04M |
| Loss Per Share | -$4.52 |
Balance Sheet
The company has $1.15 billion in cash and investments and $29.70 million in debt, with a net cash position of $1.12 billion or $11.59 per share.
| Cash & Investments | 1.15B |
| Total Debt | 29.70M |
| Net Cash | 1.12B |
| Net Cash Per Share | $11.59 |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 11.30 |
| Working Capital | 775.56M |
Cash Flow
In the last 12 months, operating cash flow was -$347.36 million and capital expenditures -$2.44 million, giving a free cash flow of -$349.80 million.
| Operating Cash Flow | -347.36M |
| Capital Expenditures | -2.44M |
| Depreciation & Amortization | 2.71M |
| Net Borrowing | n/a |
| Free Cash Flow | -349.80M |
| FCF Per Share | -$3.62 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,267.34% |
| Pretax Margin | -1,149.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IDYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.59% |
| Shareholder Yield | -5.59% |
| Earnings Yield | -14.34% |
| FCF Yield | -11.49% |
Analyst Forecast
The average price target for IDYA is $50.69, which is 60.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $50.69 |
| Price Target Difference | 60.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 8.78% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDYA has an Altman Z-Score of 12.97 and a Piotroski F-Score of 1.
| Altman Z-Score | 12.97 |
| Piotroski F-Score | 1 |